Exforge hct and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Exforge hct (amlodipine; hydrochlorothiazide; valsartan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Aspirin, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Fainting when taking Exforge hct. It is created by eHealthMe based on reports of 3,994 people who have side effects when taking Exforge hct from the FDA, and is updated regularly.

What is Exforge hct?

Exforge hct has active ingredients of amlodipine; hydrochlorothiazide; valsartan. It is often used in high blood pressure. eHealthMe is studying from 4,095 Exforge hct users. Check the latest studies of Exforge hct.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,445 drugs and 3,549 conditions by eHealthMe. Check the latest studies of Fainting.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

3,994 people reported to have side effects when taking Exforge hct.
Among them, 73 people (1.83%) have Fainting.

Among these 73 people:

How long have people been on Exforge hct when they have Fainting? *

What is the gender of people who have Fainting when taking Exforge hct? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Fainting when taking Exforge hct? *

What are other drugs people take besides Exforge hct? *

What are other side effects people have besides Fainting? *

Hypotension (abnormally low blood pressure): 22 people, 30.14%
Dizziness: 15 people, 20.55%
Memory Loss: 12 people, 16.44%
Loss Of Consciousness: 12 people, 16.44%
Headache (pain in head): 12 people, 16.44%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 13.70%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 10 people, 13.70%
Chest Pain: 9 people, 12.33%
Nausea (feeling of having an urge to vomit): 9 people, 12.33%
Fall: 8 people, 10.96%

What are the existing conditions these people have? *

High Blood Cholesterol: 8 people, 10.96%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 9.59%
Osteoporosis (bones weak and more likely to break): 5 people, 6.85%
Diabetes: 4 people, 5.48%
Memory Loss: 3 people, 4.11%
Immunodeficiency Disorders: 3 people, 4.11%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 4.11%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 2.74%
Anaemia (lack of blood): 2 people, 2.74%
Prostate Cancer: 2 people, 2.74%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge hct and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exforge hct:

Exforge hct (4,095 reports)

Fainting treatments and more:

Fainting (131,321 reports)

How severe was Fainting and when was it recovered:

Fainting in Exforge hct

Expand to all the drugs that have ingredients of amlodipine; hydrochlorothiazide; valsartan:

Fainting and drugs with ingredients of amlodipine; hydrochlorothiazide; valsartan (51 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exforge hct:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,445 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,549 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine; hydrochlorothiazide; valsartan (the active ingredients of Exforge hct) and Exforge hct (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.